Pre-surgery Treatment for Advanced Thymic Cancer
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a new treatment given before surgery for people with advanced thymic carcinoma. It aims to shrink the tumor and make surgery more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of thymus cancer called thymic carcinoma (not a neuroendocrine tumor).
- Your cancer is stage III or IVA (locally advanced) and you do not have myasthenia gravis.
- You are between 18 and 74 years old.
- You have not had any prior treatment for this cancer (like chemotherapy, radiation, or immunotherapy).
- You are in good physical shape (able to carry out daily activities) and have adequate organ function (blood counts, liver, kidneys, lungs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether additional chemotherapy after surgery can help prevent thymic cancer from coming back. It is for people who have had their thymus tumor completely removed and are in good health.
This trial studies people with thymus (thymic) cancers that have been confirmed by tissue testing. It uses tumor “molecular” (biologic/genetic) test results to guide treatment options and see how well they work.
This trial tests combining surgery with heated chemotherapy delivered directly into the chest cavity for people whose thymus cancer has spread to the lining of the lung. The goal is to see if this approach is safe and effective.
This trial tests whether combining the immunotherapy drug adebrelimab with chemoradiation before surgery can help shrink locally advanced thymic carcinoma and improve outcomes. It is for people who have not yet received treatment for their thymic carcinoma.
This study tests a combination of two drugs (tislelizumab and anlotinib) as a second treatment option for people with thymoma or thymic carcinoma whose cancer has worsened after first-line therapy. It aims to see if this combination can control the tumor and improve outcomes.
This trial tests giving radiation therapy before surgery for a type of thymus gland tumor (thymoma) that has grown into nearby tissues but has not been treated yet. The goal is to see if this approach can make the tumor removable and improve outcomes.
Hear when a new Thymic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.